Connection

Charles Swanton to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Charles Swanton has written about Antibodies, Monoclonal, Humanized.
Charles Swanton
Connection Strength
0.041
Antibodies, Monoclonal, Humanized
  1. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 2019 04; 20(4):518-530.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.